Clinical Trial Update: Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing carfilzomib-based induction (carfilzomib, melphalan, prednisone) versus bortezomib-based induction (bortezomib, melphalan, prednisone) i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib, Melphalan, Prednisone (bortezomib)
• Carfilzomib, Melphalan, Prednisone

Snippet

Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2017-08-01